I made the mistake of grabbing some at 9c only to see it tumble further. So many delays and now it's starting to look like a capital raise could be necessary to generate any decent news and I think that's current sellers biggest concern.
Struggling to believe the quarterly brain injury update. Still finalising formulation and then they're meant to get animal efficacy studies done and start a phase one trial?!?!
Stellar results in the stroke model would help and that's due mid Q2 which is a week away at most but still haven't seen anything to suggest the dosing is sorted
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.025(10.6%) |
Mkt cap ! $54.83M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 26.5¢ | 23.5¢ | $352.7K | 1.440M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3600 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 4499 | 1 |
View Market Depth
| Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
| NYR (ASX) Chart |